Cargando…

Molecular and Immune Profiling of Syngeneic Mouse Models Predict Response to Immune Checkpoint Inhibitors in Gastric Cancer

PURPOSE: Appropriate preclinical mouse models are needed to evaluate the response to immunotherapeutic agents. Immunocompetent mouse models have rarely been reported for gastric cancer. Thus, we investigated immunophenotypes and responses to immune checkpoint inhibitor (ICI) in immunocompetent mouse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Dagyeong, Choi, Junyong, Oh, Hye Jeong, Ham, In-Hye, Lee, Sung Hak, Nomura, Sachiyo, Han, Sang-Uk, Hur, Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873335/ https://www.ncbi.nlm.nih.gov/pubmed/35609622 http://dx.doi.org/10.4143/crt.2022.094

Ejemplares similares

Role of Cancer-Associated Fibroblast in Gastric Cancer Progression and Resistance to Treatments
por: Ham, In-Hye, et al.
Publicado: (2019)

Cancer-Associated Fibroblast-Induced Resistance to Chemotherapy and Radiotherapy in Gastrointestinal Cancers
por: Ham, In-Hye, et al.
Publicado: (2021)

Curcumin inhibits the cancer-associated fibroblast-derived chemoresistance of gastric cancer through the suppression of the JAK/STAT3 signaling pathway
por: Ham, In-Hye, et al.
Publicado: (2022)

Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
por: Waaler, Jo, et al.
Publicado: (2020)

Modeling Immune Checkpoint Inhibitor Efficacy in Syngeneic Mouse Tumors in an Ex Vivo Immuno-Oncology Dynamic Environment
por: Doty, Daniel T., et al.
Publicado: (2020)

Immune checkpoint blockade enhances chemophototherapy in a syngeneic pancreatic tumor model
por: Ghosh, Sanjana, et al.
Publicado: (2022)

Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
por: Ham, In-Hye, et al.
Publicado: (2019)

Properdin Is a Modulator of Tumour Immunity in a Syngeneic Mouse Melanoma Model
por: Al-Rayahi, Izzat A. M., et al.
Publicado: (2021)

Quantitative Measurement of Organic Acids in Tissues from Gastric Cancer Patients Indicates Increased Glucose Metabolism in Gastric Cancer
por: Hur, Hoon, et al.
Publicado: (2014)

Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma
por: Hur, Hoon, et al.
Publicado: (2017)

Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint Inhibitors
por: Kim, Hye Ryeon, et al.
Publicado: (2022)

Clinical Insights Into Novel Immune Checkpoint Inhibitors
por: Lee, Jii Bum, et al.
Publicado: (2021)

Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target
por: HUR, HOON, et al.
Publicado: (2012)

Enhanced Anticancer Effect of a Combination of S-adenosylmethionine (SAM) and Immune Checkpoint Inhibitor (ICPi) in a Syngeneic Mouse Model of Advanced Melanoma
por: Mehdi, Ali, et al.
Publicado: (2020)

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model
por: Piranlioglu, Raziye, et al.
Publicado: (2019)

Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model
por: Ivasko, Sara Marie, et al.
Publicado: (2023)

Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models
por: Gutierrez, Wade R., et al.
Publicado: (2021)

TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
por: Zeng, Zexian, et al.
Publicado: (2021)

A Comparison of Immune Responses Exerted Following Syngeneic, Allogeneic, and Xenogeneic Transplantation of Mesenchymal Stem Cells into the Mouse Brain
por: Hwang, Jung Won, et al.
Publicado: (2020)

Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients
por: Hur, Hoon, et al.
Publicado: (2016)

Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry
por: Park, Yujun, et al.
Publicado: (2021)

A Mouse Model of Autoimmune Cholangitis via Syngeneic Bile Duct Protein Immunization
por: Ma, Wen-Tao, et al.
Publicado: (2017)

Relationship of FDG Uptake of the Reticuloendothelial System with Tumor Immune Microenvironment and Prognosis in Patients with Gastric Cancer
por: Ahn, Hyein, et al.
Publicado: (2023)

Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models
por: Maruoka, Yasuhiro, et al.
Publicado: (2020)

Immunization with HIV protease peptides linked to syngeneic erythrocytes
por: Boberg, Andreas, et al.
Publicado: (2007)

Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
por: Lee, Yun-Gyoo, et al.
Publicado: (2021)

Transimmunization restores immune surveillance and prevents recurrence in a syngeneic mouse model of ovarian cancer
por: Alvero, Ayesha B., et al.
Publicado: (2020)

Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model
por: Wilson, Andrew J, et al.
Publicado: (2013)

AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells
por: Lee, Dakeun, et al.
Publicado: (2017)

Immune Checkpoint Inhibitors in 10 Years: Contribution of Basic Research and Clinical Application in Cancer Immunotherapy
por: Lee, Jii Bum, et al.
Publicado: (2022)

Anticancer Effect of Cold Atmospheric Plasma in Syngeneic Mouse Models of Melanoma and Colon Cancer
por: Jung, Joon-Min, et al.
Publicado: (2023)

Splenectomy is associated with an aggressive tumor growth pattern and altered host immunity in an orthotopic syngeneic murine pancreatic cancer model
por: Hwang, Ho Kyoung, et al.
Publicado: (2017)

Infiltration of Immune Competent Cells into Primary Tumors and Their Surrounding Connective Tissues in Xenograft and Syngeneic Mouse Models
por: Metzen, Marlon, et al.
Publicado: (2021)

Failure of suckling to transfer immunity to a syngeneic rat sarcoma.
por: Eccles, S. A., et al.
Publicado: (1978)

Enhanced Growth of Syngeneic Moloney Sarcoma with Decreased Immunity in the Regressors
por: Mayer, A. M. S., et al.
Publicado: (1977)

IMMUNE AND NATURAL ANTIBODIES TO SYNGENEIC MURINE PLASMA CELL TUMORS
por: Herberman, Ronald B., et al.
Publicado: (1972)

Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus
Publicado: (1984)

Decidual-Placental Immune Landscape During Syngeneic Murine Pregnancy
por: Li, Yan, et al.
Publicado: (2018)

Characterization of immune cell populations in syngeneic murine tumor models
por: Snipstad, Sofie, et al.
Publicado: (2023)

Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response
por: Sato, Yosuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4amb0i9n2l2vpavlr777tdqt62